Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Takiuchi

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[A case of gastric carcinoma treated effectively with 5'-DFUR]M Gotoh, H Takiuchi, I Hirata, et al.
British Journal of Cancer|January 14, 2012
Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patientsT Doi, H Takiuchi, A Ohtsu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 14, 2011
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancerK Inoue, Y Nakane, M Kogire, et al.
British Journal of Cancer|June 15, 2006
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancerK Yamaguchi, T Shimamura, I Hyodo, et al.
British Journal of Cancer|March 15, 2012
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trialI Mochizuki, H Takiuchi, K Ikejiri, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[A case of gastric carcinoma treated effectively with 5'-DFUR]M Gotoh, H Takiuchi, I Hirata, et al.
British Journal of Cancer|January 14, 2012
Phase I first-in-human study of TAK-285, a novel investigational dual HER2/EGFR inhibitor, in cancer patientsT Doi, H Takiuchi, A Ohtsu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 14, 2011
Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancerK Inoue, Y Nakane, M Kogire, et al.
British Journal of Cancer|June 15, 2006
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancerK Yamaguchi, T Shimamura, I Hyodo, et al.
British Journal of Cancer|March 15, 2012
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trialI Mochizuki, H Takiuchi, K Ikejiri, et al.
Pageof 6